These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway. Yang J; Kan M; Wu GY Immunopharmacol Immunotoxicol; 2016; 38(2):145-52. PubMed ID: 26954391 [TBL] [Abstract][Full Text] [Related]
45. [The effect of angiotensin-(1-7) on the mRNA expression of PDGF and TGF-beta1 in the kidney of diabetic rats]. Chen SP; Zheng JC; Ni LS; Chen GR; Zhou L Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Nov; 24(4):475-8. PubMed ID: 21158157 [TBL] [Abstract][Full Text] [Related]
46. Triphala Ameliorates Nephropathy via Inhibition of TGF-β1 and Oxidative Stress in Diabetic Rats. Suryavanshi SV; Garud MS; Barve K; Addepalli V; Utpat SV; Kulkarni YA Pharmacology; 2020; 105(11-12):681-691. PubMed ID: 32674108 [TBL] [Abstract][Full Text] [Related]
47. Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling. Hsieh TJ; Chen R; Zhang SL; Liu F; Brezniceanu ML; Whiteside CI; Fantus IG; Ingelfinger JR; Hamet P; Chan JS Kidney Int; 2006 Mar; 69(6):1005-15. PubMed ID: 16528250 [TBL] [Abstract][Full Text] [Related]
48. Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-beta1-mediated renal fibrosis and dysfunction. Tian L; Li C; Qi J; Fu P; Yu X; Li X; Cai L Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1234-42. PubMed ID: 18796544 [TBL] [Abstract][Full Text] [Related]
49. [Protective effects of Curcumin analogue L6H4 on kidney from type 2 diabetic rats]. Liu X; Ma J; Hu MT; Dong XD; Xiang LT; Gu QR; Du ZY; Chen SM; Chen GR Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jan; 33(1):11-15. PubMed ID: 29926600 [TBL] [Abstract][Full Text] [Related]
50. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis. Zakaria EM; El-Maraghy NN; Ahmed AF; Ali AA; El-Bassossy HM Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):621-631. PubMed ID: 28224182 [TBL] [Abstract][Full Text] [Related]
51. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats. Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446 [TBL] [Abstract][Full Text] [Related]
52. Gum Acacia Improves Renal Function and Ameliorates Systemic Inflammation, Oxidative and Nitrosative Stress in Streptozotocin-Induced Diabetes in Rats with Adenine-Induced Chronic Kidney Disease. Al Za'abi M; Al Salam S; Al Suleimani Y; Manoj P; Nemmar A; Ali BH Cell Physiol Biochem; 2018; 45(6):2293-2304. PubMed ID: 29550811 [TBL] [Abstract][Full Text] [Related]
53. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats. Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647 [TBL] [Abstract][Full Text] [Related]
54. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350 [TBL] [Abstract][Full Text] [Related]
55. Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells. Sharma K; Deelman L; Madesh M; Kurz B; Ciccone E; Siva S; Hu T; Zhu Y; Wang L; Henning R; Ma X; Hajnoczky G Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1258-70. PubMed ID: 12876066 [TBL] [Abstract][Full Text] [Related]
56. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Russo LM; del Re E; Brown D; Lin HY Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382 [TBL] [Abstract][Full Text] [Related]
57. Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Sharma K; Ziyadeh FN; Alzahabi B; McGowan TA; Kapoor S; Kurnik BR; Kurnik PB; Weisberg LS Diabetes; 1997 May; 46(5):854-9. PubMed ID: 9133555 [TBL] [Abstract][Full Text] [Related]
59. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat. Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607 [TBL] [Abstract][Full Text] [Related]